# Gadopiclenol vs Gadoxetate MRI for Liver Lesions

> **NCT06596616** · — · ENROLLING_BY_INVITATION · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 23 (estimated)

## Conditions studied

- Liver Lesion

## Interventions

- **OTHER:** Radiology
- **OTHER:** Gadopiclenol

## Key facts

- **NCT ID:** NCT06596616
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-07-01
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 23 (ESTIMATED)
- **Last updated:** 2026-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06596616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06596616, "Gadopiclenol vs Gadoxetate MRI for Liver Lesions". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06596616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*